GR-891

Overview

GR-891 is an acyclic nucleoside 5-Fluorouracil ( HY-90006 ) derivative. GR-891 exerts antiproliferative activity in human cancer cells and inhibits proliferation of human rhabdomyosarcoma cells. GR-891 induces terminal myogenic differentiation in human rhabdomyosarcoma cells, including modulation of desmin and vimentin expression. GR-891 is phosphorylated by kinases, incorporated into RNA, and releases acrolein. GR-891 can be used for the research of cancer and rhabdomyosarcoma.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Others | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Others | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-182403
• CAS No.: 138969-77-4
• Molecular Formula: C12H19FN2O5
• Molecular Weight: 290.29
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source